glp 1 agonist anti inflammatory GLP-1 Receptor Agonists and the Hallmarks of Aging: A Systems-Level Analysis GLP-1 Drugs: For Multiple Chronic

Pract Diabetes Int

Start with a low dose and increase gradually

Knowing this timeline helps you discuss realistic expectations with your doctor

This meta-analysis indicates that GLP-1 receptor agonists are safe and effective in modestly reducing weight, BMI, glycated hemoglobin A1c, and systolic blood pressure in children and adolescents with obesity in a clinical setting, albeit with increased rates of nausea [17]

In this article, well compound that discussion (no pun intended) a bit more by looking forward at the IP landscape - something that will become increasingly important

However, SGLT2 inhibitors have stronger evidence for renal and heart failure outcomes and are generally preferred in adults with type 2 diabetes and chronic kidney disease or heart failure, unless contraindicated or not tolerated